Works matching IS 10781552 AND DT 2019 AND VI 25 AND IP 4
Results: 42
Corrigendum: Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small cell carcinoma of the lung.
- Published in:
- 2019
- Publication type:
- Correction Notice
Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 777, doi. 10.1177/1078155217753889
- By:
- Publication type:
- Article
Efficacy of nivolumab four-weekly dosing schedule based on body weight.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 961, doi. 10.1177/1078155219833743
- By:
- Publication type:
- Article
Implementing value assessment in oncology practice: A single-center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 947, doi. 10.1177/1078155218815741
- By:
- Publication type:
- Article
Hypersensitivity to alemtuzumab. A safe and effective desensitization protocol: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1016, doi. 10.1177/1078155218775473
- By:
- Publication type:
- Article
Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1021, doi. 10.1177/1078155218815305
- By:
- Publication type:
- Article
Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 896, doi. 10.1177/1078155219832644
- By:
- Publication type:
- Article
To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 929, doi. 10.1177/1078155219831427
- By:
- Publication type:
- Article
Re: Clover et al. Transformation of a non-secretory neuro-endocrine tumor to insulinoma after treatment with Sunitinib: a case report and review of the literature. J Oncol Pharm Pract 2018. DOI: 10.1177/1078155218791309: Sunitinib-associated hyperinsulinemic hypoglycemia in patients with neuroendocrine tumors: drug-effect or tumor transformation?
- Published in:
- 2019
- By:
- Publication type:
- Letter
Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicities.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 954, doi. 10.1177/1078155218817937
- By:
- Publication type:
- Article
Clinical considerations of hyaluronidase as an adjunct to subcutaneous rituximab injection.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 964, doi. 10.1177/1078155218817819
- By:
- Publication type:
- Article
Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 903, doi. 10.1177/1078155218808080
- By:
- Publication type:
- Article
Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 884, doi. 10.1177/1078155218787286
- By:
- Publication type:
- Article
Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1003, doi. 10.1177/1078155218772327
- By:
- Publication type:
- Article
Study of the use of complementary and alternative medicine by cancer patients at Kenyatta National Hospital, Nairobi, Kenya.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 918, doi. 10.1177/1078155218805543
- By:
- Publication type:
- Article
Patient monitoring programs in oncology pharmacy practice: A survey of oncology pharmacists in Atlantic Canada.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 891, doi. 10.1177/1078155218790801
- By:
- Publication type:
- Article
Cilioretinal artery occlusion associated with cisplatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 969, doi. 10.1177/1078155218759805
- By:
- Publication type:
- Article
Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1011, doi. 10.1177/1078155218774895
- By:
- Publication type:
- Article
Capecitabine-induced myopericarditis – A case report and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 1006, doi. 10.1177/1078155218774871
- By:
- Publication type:
- Article
Intravenous radiographic contrast administered prior to high-dose methotrexate and subsequent toxicity requiring the use of glucarpidase.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 993, doi. 10.1177/1078155218769126
- By:
- Publication type:
- Article
A case–control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 875, doi. 10.1177/1078155218771461
- By:
- Publication type:
- Article
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 998, doi. 10.1177/1078155218769367
- By:
- Publication type:
- Article
The incidence and timing of leukocyte overshoot after pegfilgrastim administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 869, doi. 10.1177/1078155218769140
- By:
- Publication type:
- Article
Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 865, doi. 10.1177/1078155218769136
- By:
- Publication type:
- Article
A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer – A real world experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 793, doi. 10.1177/1078155218757856
- By:
- Publication type:
- Article
Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 990, doi. 10.1177/1078155218768875
- By:
- Publication type:
- Article
Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 855, doi. 10.1177/1078155218766408
- By:
- Publication type:
- Article
A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 847, doi. 10.1177/1078155218765629
- By:
- Publication type:
- Article
Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 841, doi. 10.1177/1078155218765627
- By:
- Publication type:
- Article
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 831, doi. 10.1177/1078155218764285
- By:
- Publication type:
- Article
Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 987, doi. 10.1177/1078155218764257
- By:
- Publication type:
- Article
Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 980, doi. 10.1177/1078155218763044
- By:
- Publication type:
- Article
Chondritis of the ear after docetaxel–carboplatin chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 975, doi. 10.1177/1078155218762629
- By:
- Publication type:
- Article
Financial impact of oral chemotherapy wastage on society and the patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 824, doi. 10.1177/1078155218762596
- By:
- Publication type:
- Article
Cystic acne due to imatinib therapy for chronic myelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 972, doi. 10.1177/1078155218761799
- By:
- Publication type:
- Article
ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 818, doi. 10.1177/1078155218760704
- By:
- Publication type:
- Article
Comparison of the effectiveness of venous thromboembolism prophylaxis with enoxaparin between obese and non-obese patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 813, doi. 10.1177/1078155218760159
- By:
- Publication type:
- Article
Evaluating the use of appropriate anticoagulation with lenalidomide and pomalidomide in patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 806, doi. 10.1177/1078155218758500
- By:
- Publication type:
- Article
Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 801, doi. 10.1177/1078155218758499
- By:
- Publication type:
- Article
Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 966, doi. 10.1177/1078155218755868
- By:
- Publication type:
- Article
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 787, doi. 10.1177/1078155218755867
- By:
- Publication type:
- Article